X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8) 8
oncology (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
female (6) 6
humans (6) 6
aged (5) 5
middle aged (5) 5
adult (4) 4
aged, 80 and over (4) 4
disease-free survival (4) 4
trial (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
breast neoplasms - drug therapy (3) 3
double-blind method (3) 3
male (3) 3
respiratory system (3) 3
aminopyridines - administration & dosage (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
bevacizumab (2) 2
breast neoplasms - pathology (2) 2
cancer (2) 2
carboplatin (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
chemotherapy (2) 2
deoxycytidine - administration & dosage (2) 2
deoxycytidine - analogs & derivatives (2) 2
double-blind (2) 2
fluorouracil - administration & dosage (2) 2
hematology, oncology and palliative medicine (2) 2
inhibitor (2) 2
kaplan-meier estimate (2) 2
leucovorin - administration & dosage (2) 2
lung cancer, non-small cell (2) 2
lung neoplasms - drug therapy (2) 2
placebo (2) 2
treatment outcome (2) 2
vascular endothelial growth factor (2) 2
1st-line therapy (1) 1
1st-line treatment (1) 1
5-ethynyluracil (1) 1
776c85 (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
agriculture (1) 1
angiogenesis (1) 1
animal husbandry (1) 1
anthracycline (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antitumor-activity (1) 1
benzimidazoles - administration & dosage (1) 1
biomarker (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - blood (1) 1
breast cancer (1) 1
breast neoplasms - enzymology (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - mortality (1) 1
cancer therapies (1) 1
capecitabine (1) 1
carboplatin - administration & dosage (1) 1
carcinoma, non-small-cell lung - blood (1) 1
carcinoma, non-small-cell lung - genetics (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, non-small-cell lung - pathology (1) 1
care and treatment (1) 1
cdk4/6 (1) 1
cdk6 (1) 1
cisplatin-gemcitabine (1) 1
clinical genotyping (1) 1
clinical-trials (1) 1
colon-cancer (1) 1
colorectal neoplasms - drug therapy (1) 1
colorectal neoplasms - mortality (1) 1
colorectal neoplasms - pathology (1) 1
colorectal-cancer (1) 1
combination therapy (1) 1
controlled-trial (1) 1
corresponding metastases (1) 1
criteria (1) 1
cultivation of vegetables, flowers, rice, fruit, vines, hopsor seaweed (1) 1
cyclin-dependent kinase 4 (1) 1
cyclin-dependent kinase 4 - antagonists & inhibitors (1) 1
cyclin-dependent kinase 6 - antagonists & inhibitors (1) 1
deoxycytidine - adverse effects (1) 1
dihydropyrimidine dehydrogenase (1) 1
dihydropyrimidine dehydrogenase-deficiency (1) 1
docetaxel (1) 1
dose-escalation (1) 1
dpd (1) 1
drug administration schedule (1) 1
e-selectin - blood (1) 1
efficacy (1) 1
endocrine therapy (1) 1
endothelial growth-factor (1) 1
epidermal growth factor (1) 1
erbb-2 protein (1) 1
estradiol - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2013, Volume 19, Issue 9, pp. 2541 - 2550
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2014, Volume 9, Issue 6, pp. 848 - 855
Avastin Biomarkers In lunG And 3D Innovative anaLysis (ABIGAIL), which is a phase II, open-label, randomized study, investigated correlations between... 
Non–small-cell lung cancer | Biomarker | Vascular endothelial growth factor | Bevacizumab | Non-small-cell lung cancer | FACTOR VEGF | ONCOLOGY-GROUP | FACTOR-A | ANGIOGENESIS | FACTOR EXPRESSION | TRIAL | ONCOLOGY | RESPIRATORY SYSTEM | PLATELETS | 1ST-LINE THERAPY | ENDOTHELIAL GROWTH-FACTOR | CISPLATIN-GEMCITABINE | Lung Neoplasms - drug therapy | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | E-Selectin - blood | Male | Pregnancy Proteins - blood | Antibodies, Monoclonal, Humanized - administration & dosage | Female | Intercellular Adhesion Molecule-1 - blood | Paclitaxel - administration & dosage | Vascular Endothelial Growth Factor Receptor-2 - analysis | Biomarkers, Tumor - analysis | Deoxycytidine - administration & dosage | Vascular Endothelial Growth Factor A - blood | Carboplatin - administration & dosage | Platelet Endothelial Cell Adhesion Molecule-1 - analysis | Vascular Endothelial Growth Factor Receptor-2 - blood | Survival Rate | Vascular Endothelial Growth Factor A - analysis | Fibroblast Growth Factor 2 - blood | Neuropilins - analysis | Biomarkers, Tumor - blood | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vascular Endothelial Growth Factor Receptor-1 - analysis | Placenta Growth Factor | Carcinoma, Non-Small-Cell Lung - blood | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Vascular Endothelial Growth Factor Receptor-1 - blood | Deoxycytidine - analogs & derivatives | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 632 - 632
Abstract Background: Approval of a biosimilar is based on it being highly similar with regard to safety, purity, and potency and with no clinically meaningful... 
Journal Article
Lung Cancer, ISSN 0169-5002, 2014, Volume 86, Issue 1, pp. 67 - 72
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.